AutoPhagyGO
Suita
About AutoPhagyGO
AutoPhagyGO offers autophagy solutions for the prevention and treatment of neurodegenerative diseases. Autophagy, the primary mechanism that controls lifespan, is controlled by its numerous aging-related occurrences and diseases may be preventable and treatable. The company uses the findings of the most recent autophagy research to promote healthy longevity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $928.4K
- Last round: Series Unknown (Mar 2022)
- Website: autophagygo.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/autophagygo-62308 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.